Role of community pharmacists in the prevention and management of the metabolic syndrome in Kuwait

Affiliations

01 February 2013

-

doi: 10.1007/s11096-012-9705-4


Abstract

Background: The metabolic syndrome is a cluster of cardiovascular risk factors and its prevalence is alarmingly high in Kuwait, affecting nearly one third of the adult population. There is lack of information about the role of community pharmacists in the care of patients with the metabolic syndrome.

Objective: To assess the awareness and opinions of community pharmacists about the metabolic syndrome and identify the services they provide for identification, management and monitoring of patients with the metabolic syndrome.

Setting: Community pharmacies in Kuwait.

Method: A descriptive, cross-sectional study was performed on a randomly selected sample of 225 community pharmacists. Data were collected via face-to-face structured interview of the pharmacists using a pre-tested questionnaire.

Main outcome measures: Pharmacists' knowledge and views on the metabolic syndrome, monitoring services provided, self-reported practices and perceived effectiveness of the various management interventions for the metabolic syndrome.

Results: The response rate was 97.8 %. Nine pharmacists claimed to know about the metabolic syndrome, but only one pharmacist could identify the condition correctly. After being given a definition of the metabolic syndrome, 67.7 % of respondents strongly agreed that its prevalence was rising in Kuwait. Nearly two thirds of respondents reported providing height and weight measurement service while 82.7 and 59.5 % of pharmacies provided blood pressure and blood glucose measurements, respectively. Waist circumference and lipid profile measurements were the least provided services (1.8 %). Respondents claimed to be involved in counseling patients on lifestyle modifications including increased exercise (98.1 %) and weight reduction through diet (96.9 %). Most pharmacists were involved in encouraging patients' adherence with prescribed treatments (98.6 %) and perceived these as the most effective intervention for the management of the metabolic syndrome (95.0 %). Respondents were less involved in monitoring patients' response to therapy (75.0 %) and documenting patient care services (5.0 %).

Conclusion: This study revealed significant deficits in awareness among community pharmacists about the metabolic syndrome. Given the proper education and training, community pharmacists could be important front-line contributors to the control of this emerging epidemic in Kuwait.


Similar articles

Community Pharmacists role in obesity treatment in Kuwait: a cross-sectional study.

Awad A, Waheedi M.BMC Public Health. 2012 Oct 11;12:863. doi: 10.1186/1471-2458-12-863.PMID: 23057422 Free PMC article.

Health promotion and education activities of community pharmacists in Kuwait.

Awad A, Abahussain E.Pharm World Sci. 2010 Apr;32(2):146-53. doi: 10.1007/s11096-009-9360-6. Epub 2009 Dec 29.PMID: 20039206

Self-monitoring of blood pressure and the role of community pharmacists in Kuwait.

Matowe WC, Abahussain EA, Awad A, Capps PA.Med Princ Pract. 2008;17(1):27-31. doi: 10.1159/000109586.PMID: 18059097

Community pharmacists' services for women during pregnancy and breast feeding in Kuwait: a cross-sectional study.

Albassam A, Awad A.BMJ Open. 2018 Jan 5;8(1):e018980. doi: 10.1136/bmjopen-2017-018980.PMID: 29306891 Free PMC article.

Community pharmacists' role in caring for people living with epilepsy: A scoping review.

Bacci JL, Zaraa S, Stergachis A, Simic G, White HS.Epilepsy Behav. 2021 Apr;117:107850. doi: 10.1016/j.yebeh.2021.107850. Epub 2021 Feb 23.PMID: 33631435 Review.


Cited by

Pharmacists' involvements and barriers in the provision of health promotion services towards noncommunicable diseases: Community-based cross-sectional study in Northwest Ethiopia.

Sendekie AK, Dagnaw AD, Dagnew EM.Arch Public Health. 2023 Feb 25;81(1):31. doi: 10.1186/s13690-023-01038-x.PMID: 36841787 Free PMC article.

Multicenter Cross-Sectional Study on Perceptions and Roles of Community Pharmacists in the Prevention and Management of Cardiovascular Disorders in Northwest Ethiopia.

Sendekie AK, Netere AK.Integr Pharm Res Pract. 2022 Jan 19;11:21-31. doi: 10.2147/IPRP.S348260. eCollection 2022.PMID: 35083130 Free PMC article.

A cross sectional study on beliefs and roles of community pharmacy professionals in preventing and managing metabolic syndrome in an Ethiopian setting.

Belachew SA, Muluneh NY, Erku DA, Netere AK.PLoS One. 2020 Dec 21;15(12):e0244211. doi: 10.1371/journal.pone.0244211. eCollection 2020.PMID: 33347490 Free PMC article.

Pharmaceutical care education in Kuwait: pharmacy students' perspectives.

Katoue MG, Awad AI, Schwinghammer TL, Kombian SB.Pharm Pract (Granada). 2014 Jul;12(3):411. doi: 10.4321/s1886-36552014000300002. Epub 2014 Sep 4.PMID: 25243027 Free PMC article.

Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study.

Via-Sosa MA, Toro C, Travé P, March MA.BMC Public Health. 2014 May 22;14:487. doi: 10.1186/1471-2458-14-487.PMID: 24885099 Free PMC article.


KMEL References


References

  1.  
    1. Pharmacotherapy. 2009 Aug;29(8):975-87 - PubMed
  2.  
    1. BMC Health Serv Res. 2010 Feb 05;10:34 - PubMed
  3.  
    1. Pharm World Sci. 2010 Apr;32(2):146-53 - PubMed
  4.  
    1. J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32 - PubMed
  5.  
    1. Med Princ Pract. 2008;17(4):270-5 - PubMed
  6.  
    1. Diabetes Care. 2001 Apr;24(4):683-9 - PubMed
  7.  
    1. Ann Pharmacother. 2004 Nov;38(11):1800-4 - PubMed
  8.  
    1. Ann Pharmacother. 2010 Jan;44(1):88-96 - PubMed
  9.  
    1. J Am Pharm Assoc (2003). 2004 Sep-Oct;44(5):562-8 - PubMed
  10.  
    1. Am J Med. 2004 Jan 15;116(2):130-3 - PubMed
  11.  
    1. Am Pharm. 1995;Suppl:13-8 - PubMed
  12.  
    1. Med Princ Pract. 2004 Jan-Feb;13(1):39-42 - PubMed
  13.  
    1. Ann Pharmacother. 2004 Nov;38(11):1961-3 - PubMed
  14.  
    1. Diabet Med. 2007 Jun;24(6):677-83 - PubMed
  15.  
    1. Angiology. 2010 Feb-Mar;61(1):42-8 - PubMed
  16.  
    1. J Manag Care Pharm. 2011 May;17(4):295-303 - PubMed
  17.  
    1. J Am Pharm Assoc (Wash). 2000 Mar-Apr;40(2):157-65 - PubMed
  18.  
    1. J Rural Health. 2011 Spring;27(2):184-9 - PubMed
  19.  
    1. J Hypertens. 2007 Jun;25(6):1105-87 - PubMed
  20.  
    1. Circulation. 2009 Oct 20;120(16):1640-5 - PubMed
  21.  
    1. J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):32-6 - PubMed
  22.  
    1. Am J Health Syst Pharm. 2003 Aug 1;60(15):1591-2 - PubMed
  23.  
    1. Can J Clin Pharmacol. 2003 Fall;10(3):101-6 - PubMed
  24.  
    1. J Am Pharm Assoc (2003). 2006 May-Jun;46(3):370-7 - PubMed
  25.  
    1. Fam Med. 2004 Sep;36(8):540 - PubMed
  26.  
    1. Addiction. 2001 Feb;96(2):325-31 - PubMed
  27.  
    1. J Atheroscler Thromb. 2006 Oct;13(5):221-6 - PubMed
  28.  
    1. N Engl J Med. 2002 Feb 7;346(6):393-403 - PubMed
  29.  
    1. Pharm World Sci. 2006 Apr;28(2):65-72 - PubMed
  30.  
    1. Obesity (Silver Spring). 2008 Apr;16(4):834-40 - PubMed